Key result
Evidence supports statin therapy for early dyslipidemia in mild to moderate CKD.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tsimihodimos et al. (2008) conducted a review in Chronic Kidney Disease and Dyslipidemia. Lipid-lowering therapy was evaluated. Dyslipidemia is an early complication of chronic kidney disease characterized by hypertriglyceridemia, and current evidence supports the use of statins in patients with mild to moderate CKD.
Synapse has enriched 5 related papers. Consider them for comparative context: